The Pharmacy Times® Cardiovascular Health Resource Center is a comprehensive resource for clinical news and expert insights on the health of the heart and blood vessels, including coronary heart disease, stroke, heart failure, heart arrhythmias, and heart valve issues.
July 1st 2025
Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis.
Recent Developments in the Management of Heart Failure With Preserved Ejection Fraction
1.0 Credit / Cardiology
View More
Therapies in Lowering LDL-Cholesterol Levels for the Primary and Secondary Prevention of Atherosclerotic Cardi...
0.75 Credit / Cardiology
View More
Updated Guidelines in the Management of Atrial Fibrillation and Application for Pharmacists
1.5 Credits / Cardiology
View More
Elevating Cardiac Care: Insights From Pharmacists Across Practice Settings
1.0 Credit / Cardiology
View More
The Expanding Role of Nonstatin Therapies in Reducing LDL-Cholesterol Levels to Prevent and Manage ASCVD: A Re...
1.5 Credits / Cardiology
View More
The Evolving Treatment Paradigm for the Management of Pulmonary Arterial Hypertension: Strategies to Optimize ...
1.5 Credits / Cardiology
View More
Lipoprotein(a) and Beyond: Emerging Paradigms in Atherosclerotic Cardiovascular Disease Prevention
1.5 Credits / Cardiology
View More
Optimizing Care for Chronic Worsening Heart Failure: The Key Role of Pharmacists in Integrating Therapies
1.5 Credits / Cardiology
View More
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
1 Credit / Cardiology, Neurology
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Harnessing the Potential of SGLT2 Inhibitors in Cardiorenal Metabolic Health: Strategies for Long-term Care an...
1.0 Credit / Cardiology, Endocrinology, Diabetes, & Metabolism, Nephrology
View More
Mastering Hypertrophic Cardiomyopathy: Cutting-Edge Therapies for Better Outcomes
1.5 Credits / Cardiology
View More
Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy
1.0 Credit / Cardiology
View More
Exploring Advances in the Management of DOAC-Associated Bleeding With Reversal Agents: Role of the Health-Syst...
1.5 Credits / Cardiology, Patient Safety
View More
Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines
1.0 Credit / Cardiology
View More
Hyperlipidemia Overview and the Clinical and Economic Burden
1.0 Credit / Cardiology
View More
Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence
0.5 Credit / Cardiology
View More
The Role of the Pharmacist in the Management of Hyperlipidemia
1.0 Credit / Cardiology
View More
Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative
1.5 Credits / Cardiology
View More
The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies
1.5 Credits / Cardiology, Rare Diseases
View More
PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices
0.75 Credit / Oncology, Law
View More
Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies
1.5 Credits / Pulmonology, Cardiology, Rare Diseases
View More
Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines
1.0 Credit / Cardiology
View More
The Role of IV Iron in Resolving Iron Deficiency in Heart Failure
1.0 Credit / Cardiology, Gastroenterology, General Pharmacy, Oncology, Women's Health
View More
From Guidelines to Practice: The Pharmacist’s Role in Chronic Heart Failure Therapy Optimization
1.5 Credits / Cardiology
View More
Cutting Copayments Improves Outcomes for Minority Patients After Heart Attack
May 19th 2014When nonwhite heart attack patients were able to obtain cardiovascular medications without a copayment, their readmission rates for a major vascular event or coronary revascularization dropped significantly.
Read More
Spironolactone Produces Mixed Results in Heart Failure Patients with a Preserved Ejection Fraction
May 14th 2014Trial finds that spironolactone significantly reduced hospitalization for heart failure in heart failure patients with a preserved ejection fraction but failed to decrease the incidence of the trial's primary composite outcome.
Read More
National Initiative Improves Treatment Times, Outcomes for Stroke Patients
May 6th 2014The Target: Stroke initiative reduced the time before acute ischemic stroke patients were treated with intravenous tissue plasminogen activator, leading to reduced rates of in-hospital mortality and intracranial hemorrhage.
Read More
Home Monitoring Improves INR Control for Warfarin Patients
April 4th 2014Patients who self-monitored their international normalized ratio weekly achieved significantly better control than those who did so less frequently, but all home monitoring patients performed well, according to a new study.
Read More